C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d

  1. Kowalska, D.
  2. Kuźniewska, A.
  3. Senent, Y.
  4. Tavira, B.
  5. Inogés, S.
  6. López-Díaz de Cerio, A.
  7. Pio, R.
  8. Okrój, M.
  9. Yuste, J.R.
Journal:
Frontiers in Immunology

ISSN: 1664-3224

Year of publication: 2022

Volume: 13

Type: Article

DOI: 10.3389/FIMMU.2022.946522 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus